U.S. Marine and Shipping Stock News

NasdaqGS:LPLA
NasdaqGS:LPLACapital Markets

Is LPL Financial Holdings (LPLA) Undervalued On HighWater Wealth’s $2.4b Advisor Move?

LPL Financial Holdings (LPLA) is in focus after HighWater Wealth, a multi family office team reporting about $2.4b in advisory assets, joined its broker dealer and RIA platform from U.S. Bank. See our latest analysis for LPL Financial Holdings. At a share price of $324.9, LPL Financial Holdings has seen a 10.53% 1 month share price return and a decline of 10.16% year to date, while its 5 year total shareholder return of 139.33% points to stronger longer term momentum. If this kind of advisor...
NYSE:MRK
NYSE:MRKPharmaceuticals

Merck (MRK) Stock Looks Cheap On Cash Flow While Earnings Look Fair

Merck stock has delivered a strong 92.2% return over the past 5 years, yet its current valuation picture is mixed, with the Discounted Cash Flow (DCF) intrinsic value estimate suggesting the shares may sit below what the underlying cash flows imply while market multiples look closer to fair. A 92.2% gain over 5 years puts Merck among the stronger large pharma performers, which raises the question of how much of its pipeline and cash flow potential is already reflected in the price. Recent...
NYSE:VMC
NYSE:VMCBasic Materials

Is Vulcan Materials (VMC) Undervalued As It Reaffirms Its Dividend?

Vulcan Materials (VMC) has affirmed its shareholder payout, with the board declaring a quarterly cash dividend of $0.52 per share. The dividend is payable on September 2, 2026, to shareholders of record on August 13, 2026. See our latest analysis for Vulcan Materials. Vulcan Materials’ recent dividend decision comes as the stock edges lower in the short term, with the share price down 4.8% over the past month and modestly lower year to date. However, 1 year and multi year total shareholder...
NasdaqGS:CSWC
NasdaqGS:CSWCCapital Markets

Preliminary Net Investment Income Guidance Might Change The Case For Investing In Capital Southwest (CSWC)

Capital Southwest Corporation has released preliminary guidance for the quarter ended June 30, 2026, estimating pre-tax net investment income of $0.57–$0.58 per share and net investment income of $0.58–$0.59 per share. This early look at quarterly net investment income gives investors a clearer view of how the firm's lending and investment portfolio is currently performing. Next, we’ll examine how this preliminary net investment income range could influence Capital Southwest’s investment...
NasdaqGS:ASTS
NasdaqGS:ASTSTelecom

AST SpaceMobile (ASTS) Completes $1b Convertible Notes, Is The 66% Upside Case Still Credible?

AST SpaceMobile (ASTS) has become a focus for investors after completing a US$1b convertible note issuance. This move reshapes its capital structure while funding ambitions for its satellite based cellular broadband network. See our latest analysis for AST SpaceMobile. Recent volatility in AST SpaceMobile reflects that tension clearly, with the share price up 5.07% over the past day but showing a 30 day share price return that is down 28.34% and a year to date share price return that is down...
NasdaqGS:AMSC
NasdaqGS:AMSCElectrical

Vertiv Stock And 2 Power Grid Plays Backing The AI Data Center Buildout

The power grid is quietly becoming one of the most important bottlenecks in global growth, as AI data centers, electric vehicles and electrification push energy demand higher while inflation, rates and mixed growth signals keep investors cautious. Instead of guessing where consumer sentiment or central banks move next, some investors are looking at the core infrastructure that makes any growth story possible: the high density power systems that keep the lights on. This Power Grid Technology...
NYSE:HLF
NYSE:HLFPersonal Products

Is Herbalife (HLF) Undervalued After Its Fuel Like Ronaldo Recovery Push?

Herbalife (HLF) has expanded its global Fuel Like Ronaldo campaign with detailed post match recovery guidance, introducing a 4 R framework that links nutrition and hydration choices to athletic recovery and future performance readiness. See our latest analysis for Herbalife. Despite the Fuel Like Ronaldo campaign raising Herbalife’s profile, the stock has come under pressure lately, with the share price falling over the past week and three months. The 1 year total shareholder return remains...
NYSE:NEE
NYSE:NEEElectric Utilities

NextEra Energy (NEE) Faces New Questions After New York Pauses Large Data Centers

New York has imposed a moratorium on new large data center projects, citing pressure on the state's power infrastructure. The decision comes as AI related electricity demand draws increased attention to grid capacity and reliability across the US. The move puts utilities and clean energy companies such as NextEra Energy (NYSE:NEE) in sharper focus as potential providers of future data center power solutions. For investors watching NextEra Energy, the New York pause on large data centers...
NYSE:SLG
NYSE:SLGOffice REITs

SL Green Realty (SLG) Following Tokyo SUMMIT Expansion Has Its Valuation Back In Focus

SL Green Realty (SLG) is back in focus after announcing that SUMMIT Entertainment Ventures, its joint venture with Kenzo Digital, will bring the SUMMIT immersive observatory experience to Tokyo as part of a growing global expansion. See our latest analysis for SL Green Realty. At a share price of $51.54, SL Green Realty has seen a 16.92% 90 day share price return and a 74.81% three year total shareholder return. However, the 1 year total shareholder return is down 9.72%, suggesting longer...
NasdaqGM:PTGX
NasdaqGM:PTGXBiotechs

Protagonist Therapeutics (PTGX) Rises In Biotech Rally While Valuation Keeps The Debate Open

Protagonist Therapeutics (PTGX) moved 5.7% higher as investors bought into a broad biotech rally, with the stock participating in a sector wide rotation into biotechnology rather than reacting to company specific headlines. See our latest analysis for Protagonist Therapeutics. With Protagonist Therapeutics trading at US$140.91 and logging a 24.85% 1 month share price return and 61.63% year to date share price return, the strong 1 year total shareholder return of 153.98% and very large 3 year...
NYSE:MTDR
NYSE:MTDROil and Gas

Matador’s Weakest-In-Peer EBITDA Miss Might Change The Case For Investing In Matador Resources (MTDR)

Earlier this year, Matador Resources reported quarterly results that fell short of analysts’ revenue and EBITDA estimates, marking the weakest performance among its U.S. shale exploration and production peers. This earnings disappointment raises questions about how effectively Matador’s operations and midstream expansion are translating into financial resilience relative to competitors. Next, we’ll examine how this earnings miss, particularly on EBITDA, could affect Matador’s previously...
NasdaqGS:ETOR
NasdaqGS:ETORCapital Markets

eToro Group (ETOR) Slides As Bullish Fair Value Narrative Faces A Fresh Test

Recent Trading Performance for eToro Group eToro Group (NasdaqGS:ETOR) has drawn investor attention after its stock closed at $35.98, with returns down 3.9% over the past day and down 8.1% over the past week. See our latest analysis for eToro Group. For eToro Group, the recent 1 day and 7 day share price declines come on top of a weaker 1 year total shareholder return. This suggests momentum has faded compared with the start of the year, even though the year to date share price return is...
NYSE:USB
NYSE:USBBanks

U.S. Bancorp (USB) Stock Could Be A Bargain As Fair Value Tops Earnings Price

U.S. Bancorp stock has delivered a 3 year return of 87.8%, yet the current checks suggest the shares may still trade below an intrinsic value estimate that screens as undervalued on both an Excess Returns model and earnings multiples. Over the past 3 years, U.S. Bancorp has returned 87.8%, which puts extra focus on whether recent gains have already captured most of the value in the business. New digital payment offerings such as Enhanced Payments can support expectations for more efficient...
NYSE:TWLO
NYSE:TWLOIT

Twilio (TWLO) Beats Q1 Expectations, Is The Stock Still Fully Valued?

Twilio Q1 beat puts recent share gains in focus Twilio (TWLO) drew fresh investor attention after reporting Q1 revenue growth of 20% year on year, a 4.7% beat versus analyst expectations, alongside stronger net revenue retention and billings estimates. See our latest analysis for Twilio. Twilio's strong Q1 has come on top of a sharp share price re-rating, with the stock up 42.0% over 90 days and a 1 year total shareholder return of 57.85%, although the 5 year total shareholder return is down...
NYSE:SPH
NYSE:SPHGas Utilities

Is Suburban Propane Partners (SPH) Undervalued After Industry Tailwinds Lifted Its Margin Outlook?

Recent industry commentary has put Suburban Propane Partners (SPH) in focus, citing the Oil and Gas Refining & Marketing MLP sector’s fee-based structure and tight refined-product inventories as supportive factors for margins and future earnings estimates. See our latest analysis for Suburban Propane Partners. At a share price of $18.12, Suburban Propane Partners has seen a 9.49% 1 month share price return, while its 1 year total shareholder return of 5.39% and 3 year total shareholder return...
NYSE:AU
NYSE:AUMetals and Mining

AngloGold Ashanti Stock Leads 3 Balance Sheet Picks For Defensive Investors

With inflation trends easing in several major economies, central banks taking a data driven approach to rates, and earnings expectations increasingly tied to real cash generation, many investors are looking for companies that already show high return on equity, solid past performance and strong balance sheets. That is exactly what the Solid Balance Sheet and Fundamentals screener is built to highlight. In this article, you will see three stocks from the screener that combine quality...
NYSE:TRU
NYSE:TRUProfessional Services

Is TransUnion’s (TRU) Alternative Data Push Quietly Redefining Its Core Competitive Edge?

In July 2026, TransUnion enhanced its mortgage credit report by integrating TruVision Alternative Credit Attributes (ACA 2.0) from the FactorTrust Alternative Lending Database, giving lenders broader visibility beyond traditional credit data at no additional cost. This move deepens mortgage risk assessments by layering alternative financial signals alongside trended and soft-check data, aiming to sharpen early-stage underwriting decisions and improve overall decision quality for lenders...
NYSE:BMY
NYSE:BMYPharmaceuticals

Bristol Myers (BMY) Is Up 5.5% After FDA Accepts Mezigdomide NDA In Multiple Myeloma

In July 2026, Bristol Myers Squibb announced that the FDA accepted its New Drug Application for mezigdomide in combination with carfilzomib and dexamethasone to treat relapsed or refractory multiple myeloma, backed by Phase 3 data showing a clinically meaningful improvement in progression-free survival versus standard of care. An interesting aspect of this update is that the SUCCESSOR-2 trial enrolled a heavily pretreated, mostly triple-class-exposed patient population, highlighting...